Visalytics
Visalytics
approved EB-2 (NIW)

Fellow Physician

Hematology And Medical Oncology · India · 2025-05-23

Processing Time
341 days
Decision Date
2025-05-23
Location
New York
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to conduct high-quality clinical trials and literature reviews to discover new therapeutics and refine treatment protocols for hematologic malignancies and solid organ cancers. Her work focuses on enrolling patients in trials and synthesizing data on modern treatment approaches to improve care outcomes for patients with serious oncological conditions.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses urgent national healthcare needs by improving treatment protocols for cancer and blood disorders.

2 Well-positioned to Advance the Endeavor Met

The petitioner is well-positioned due to her extensive background in internal medicine, 14 peer-reviewed publications, and high citation metrics.

3 Waiver Benefit Met

On balance, it is beneficial to the U.S. to waive the job offer requirement given the petitioner's proven track record in advancing oncological research.

Why This Petition Was Approved

The petition was approved based on the petitioner's academic record of 14 peer-reviewed journal articles and 5 abstracts, which accumulated 171 citations. Specific evidence included papers ranking in the top 10% and 20% of their field, with one COVID-19-related article ranking in the top 0.1% of citations. The case demonstrated her influence in surgical safety, drug safety, and thrombosis research, satisfying the Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · Vietnam

WeGreened EB-2 (NIW) approved
Pennsylvania 103 days 2023-05-26
The petitioner proposes to introduce, evaluate, and refine innovative precision therapies to improve the treatment of leukemia and other blood cancers. This work focuses on developing targeted medical interventions to enhance clinical outcomes for patients with hematologic malignancies.
View Case

Assistant Professor

Healthcare · China

WeGreened EB-2 (NIW) approved
Pennsylvania 40 days 2025-05-13
The petitioner proposes to enhance CAR-T cell therapy for hematological malignancies by integrating laboratory research with patient-centered clinical trials. The work focuses on closing the translational gap to bring immunotherapy discoveries into clinical practice for leukemia and other blood cancers. The goal is to develop therapies that are more precise, responsive, and accessible to patients.
View Case

Assistant Professor

Healthcare · Lebanon

WeGreened EB-2 (NIW) approved
New York 283 days 2025-02-14
The petitioner proposes to continue his clinical research in precision oncology and immune profiling, focusing on the use of biomarkers to improve the diagnosis and treatment of complex cancers such as renal cell carcinoma and multiple myeloma. His work involves the development and validation of novel imaging and staining techniques to better understand immune microenvironments and treatment responses.
View Case

Others

Healthcare · Pakistan

WeGreened EB-2 (NIW) approved
Florida 9 days 2025-04-20
The petitioner proposes to investigate the advanced histologic, immunologic, and molecular characteristics of malignant tissues, specifically focusing on breast, renal, gastrointestinal, and hematolymphoid neoplasms. His work aims to elevate the accuracy of pathology-based diagnostics using cutting-edge laboratory techniques to enhance diagnostic precision and support the discovery of novel treatment strategies.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Healthcare cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2025-05-23.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 341 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,816
Success Rate 53.6%
Sustained 2,046
Dismissed 1,674

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist